Published in Arthritis Rheum on March 01, 2000
Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial (TERA) | NCT01400516
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther (2009) 3.47
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis (2013) 3.25
Low-energy distal radius fractures in middle-aged and elderly men and women--the burden of osteoporosis and fracture risk : A study of 1794 consecutive patients. Osteoporos Int (2009) 2.77
Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Ann Rheum Dis (2004) 1.73
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.64
Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther (2010) 1.48
Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis. J Bone Miner Res (2013) 1.44
Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss. Arthritis Res Ther (2007) 1.37
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis (2004) 1.30
Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis (2003) 1.22
Osteoporosis in inflammatory joint diseases. Osteoporos Int (2010) 1.21
Osteoimmunology and osteoporosis. Arthritis Res Ther (2011) 1.20
Osteoprotegerin and RANKL in the pathogenesis of rheumatoid arthritis-induced osteoporosis. Rheumatol Int (2011) 1.17
Arthritis increases the risk for fractures--results from the Women's Health Initiative. J Rheumatol (2011) 1.05
Prevalence of vertebral fractures in patients with rheumatoid arthritis: revisiting the role of glucocorticoids. Osteoporos Int (2011) 1.04
Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis (2004) 1.04
Occurrence and risk factors for falls in rheumatoid arthritis. Ann Rheum Dis (2005) 1.04
Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation. Arthritis Res Ther (2005) 1.02
Can bone loss in rheumatoid arthritis be prevented? Osteoporos Int (2013) 1.02
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis. Ann Rheum Dis (2007) 1.01
A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther (2010) 0.98
Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis. Ann Rheum Dis (2000) 0.96
High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int (2011) 0.93
Bone mineral density in patients with hand osteoarthritis compared to population controls and patients with rheumatoid arthritis. Ann Rheum Dis (2007) 0.93
A comparison of three different guidelines for osteoporosis treatment in patients with rheumatoid arthritis in Korea. Korean J Intern Med (2010) 0.92
Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population. Rheumatol Int (2010) 0.92
Association of bone mineral density and vertebral deformity in patients with rheumatoid arthritis. Rheumatol Int (2007) 0.92
Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis. Rheumatol Int (2008) 0.91
Risk factors for vertebral fracture in menopausal or postmenopausal Japanese women with rheumatoid arthritis: a cross-sectional and longitudinal study. J Bone Miner Metab (2006) 0.90
Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int (2006) 0.88
Bone loss. Therapeutic approaches for preventing bone loss in inflammatory arthritis. Arthritis Res (2001) 0.88
The limited effects of anti-tumor necrosis factor blockade on bone health in patients with rheumatoid arthritis under the use of glucocorticoid. J Bone Miner Metab (2014) 0.87
Inflammatory rheumatic disorders and bone. Curr Rheumatol Rep (2012) 0.85
Initiation of tumor necrosis factor α antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken) (2013) 0.85
Effects of anti-tumor necrosis factor α agents on bone. Curr Opin Rheumatol (2012) 0.84
Bone mineral density by digital X-ray radiogrammetry is strongly decreased and associated with joint destruction in long-standing rheumatoid arthritis: a cross-sectional study. BMC Musculoskelet Disord (2011) 0.84
Bisphosphonates for the prevention and treatment of osteoporosis in patients with rheumatic diseases: a systematic review and meta-analysis. PLoS One (2013) 0.83
Incidence of vertebral deformities in 255 female rheumatoid arthritis patients measured by morphometric X-ray absorptiometry. Osteoporos Int (2004) 0.83
Comparison of ultrasound and X-ray absorptiometry bone measurements in a case control study of female rheumatoid arthritis patients and randomly selected subjects in the population. Osteoporos Int (2003) 0.83
[Insufficiency fractures in rheumatology. Case report and overview]. Z Rheumatol (2006) 0.83
Bone mineral density in Indian women with rheumatoid arthritis. Rheumatol Int (2008) 0.82
Risk factors associated with incident fractures in Japanese men with rheumatoid arthritis: a prospective observational cohort study. J Bone Miner Metab (2008) 0.82
Mediastinal migration of distal occipito-thoracic instrumentation. Eur Spine J (2007) 0.81
Generalized bone loss as a predictor of three-year radiographic damage in African American patients with recent-onset rheumatoid arthritis. Arthritis Rheum (2010) 0.81
Reduction of urinary levels of pyridinoline and deoxypyridinoline and serum levels of soluble receptor activator of NF-kappaB ligand by etanercept in patients with rheumatoid arthritis. Clin Rheumatol (2008) 0.81
What is the prevalence of rheumatic disorders in general medical inpatients? Postgrad Med J (2001) 0.81
Sustained maintenance of exercise induced muscle strength gains and normal bone mineral density in patients with early rheumatoid arthritis: a 5 year follow up. Ann Rheum Dis (2004) 0.81
Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study. Ann Rheum Dis (2004) 0.81
Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures. Clin Rheumatol (2013) 0.81
Outcome of balloon kyphoplasty for the treatment of osteoporotic vertebral compression fracture in patients with rheumatoid arthritis. BMC Musculoskelet Disord (2016) 0.80
Prevalence and associated factors of osteoporosis in female patients with rheumatoid arthritis. Caspian J Intern Med (2012) 0.80
Bone mineral density and frequency of osteoporosis among Vietnamese women with early rheumatoid arthritis. Clin Rheumatol (2011) 0.80
The final pathogenetic steps in focal bone erosions in rheumatoid arthritis. Ann Rheum Dis (2000) 0.79
Outdoor air pollution and bone mineral density in elderly men - the Oslo Health Study. Osteoporos Int (2007) 0.79
Osteoporosis in psoriatic arthritis: is there any? Wien Klin Wochenschr (2011) 0.79
Quantitative ultrasound and bone mineral density: discriminatory ability in patients with rheumatoid arthritis and controls with and without vertebral deformities. Ann Rheum Dis (2004) 0.79
Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int (2016) 0.79
Reducing glucocorticoid dosage improves serum osteocalcin in patients with rheumatoid arthritis-results from the TOMORROW study. Osteoporos Int (2015) 0.78
Inhibitory effect of bone resorption and inflammation with etidronate therapy in patients with rheumatoid arthritis for 3 years and in vitro assay in arthritis models. Rheumatol Int (2005) 0.78
The frequency of and risk factors for osteoporosis in Korean patients with rheumatoid arthritis. BMC Musculoskelet Disord (2016) 0.78
Bone Mineral Density, Bone Turnover, and Systemic Inflammation in Non-cirrhotics with Chronic Hepatitis C. Dig Dis Sci (2015) 0.78
The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatol Int (2003) 0.78
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis. Arthritis Res Ther (2016) 0.78
Association between rheumatoid arthritics and osteoporosis among Chinese men, a community based study. Int J Clin Exp Med (2015) 0.78
A study of the link between bone turnover markers and bone mineral density with inflammation and body mass in postmenopausal women with active rheumatoid arthritis. J Bone Miner Metab (2012) 0.77
A three month controlled intervention of intermittent whole body vibration designed to improve functional ability and attenuate bone loss in patients with rheumatoid arthritis. BMC Musculoskelet Disord (2014) 0.77
Height Restoration after Balloon Kyphoplasty in Rheumatoid Patients with Osteoporotic Vertebral Compression Fracture. Asian Spine J (2015) 0.77
Bone status in rheumatoid arthritis assessed at peripheral sites by three different quantitative ultrasound devices. Clin Rheumatol (2004) 0.77
Bone-density testing interval and transition to osteoporosis in patients with rheumatoid arthritis. Osteoporos Int (2016) 0.77
Can bone quality be predicted accurately by Singh index in patients with rheumatoid arthritis? Clin Rheumatol (2011) 0.76
The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Rheumatol Int (2005) 0.76
Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study. Medicine (Baltimore) (2016) 0.76
Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease. Osteoporos Int (2012) 0.76
The risk of osteoporotic fractures according to the FRAX model in Korean patients with rheumatoid arthritis. J Korean Med Sci (2014) 0.76
[Bone densitometry in inflammatory rheumatic diseases : Characteristics of the measurement site and disease-specific factors]. Z Rheumatol (2009) 0.75
Alendronate prevents glucocorticoid-induced osteoporosis in patients with rheumatic diseases: A meta-analysis. Medicine (Baltimore) (2016) 0.75
Osteoporosis in adult patients with atopic dermatitis: A nationwide population-based study. PLoS One (2017) 0.75
A review of the use of dual-energy X-ray absorptiometry (DXA) in rheumatology. Open Access Rheumatol (2012) 0.75
Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMDa) in women with longstanding inflammatory polyarthritis: a primary care based inception cohort. BMC Musculoskelet Disord (2010) 0.75
Rheumatoid arthritis is associated with less optimal hip structural geometry. J Clin Densitom (2011) 0.75
Glucocorticoids: bad or safe for the bones? RMD Open (2015) 0.75
Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era. BMC Musculoskelet Disord (2014) 0.75
Whole body bone tissue and cardiovascular risk in rheumatoid arthritis. J Osteoporos (2014) 0.75
Biologicals and bone loss. Ther Adv Musculoskelet Dis (2012) 0.75
Dual X-Ray Absorptiometry Whole Body Composition of Bone Tissue in Rheumatoid Arthritis - a Cross-Sectional Study. Maedica (Buchar) (2015) 0.75
Failure of a carbon fiber-reinforced polymer implant used for transforaminal lumbar interbody fusion. Global Spine J (2013) 0.75
Influence of inflammatory polyarthritis on quantitative heel ultrasound measurements. BMC Musculoskelet Disord (2012) 0.75
Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients. Rheumatol Int (2017) 0.75
Using hand bone mass measurements to assess progression of rheumatoid arthritis. Ther Adv Musculoskelet Dis (2010) 0.75
Relation between bone mineral density and IL-17 serum levels in Serbian patients with early Rheumatoid arthritis. Open Med (Wars) (2014) 0.75
Increased risk of vertebral fracture in patients with rheumatoid arthritis: A meta-analysis. Medicine (Baltimore) (2016) 0.75
Lack of association of oral calcium supplementation with coronary artery calcification in rheumatoid arthritis. Arthritis Rheumatol (2015) 0.75
OsteoRheumatology: a new discipline? RMD Open (2015) 0.75
Incidence of comprehensive hospitalization due to infection, cardiovascular disease, fractures, and malignancies in patients with rheumatoid arthritis. Rheumatol Int (2017) 0.75
Relationship between bone mineral density and urine level of NTx in rheumatoid arthritis. J Bone Miner Metab (2005) 0.75
Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA. Rheumatol Int (2016) 0.75
Effect of celastrol on bone structure and mechanics in arthritic rats. RMD Open (2017) 0.75
Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach. PLoS One (2017) 0.75
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol (1999) 2.93
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet (2000) 2.63
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 2.37
Factors associated with mortality after hip fracture. Osteoporos Int (2000) 2.35
Intra-atrial ECG is not a reliable method for positioning left internal jugular vein catheters. Br J Anaesth (2003) 2.21
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis (2011) 2.06
The role of somatosensory evoked potentials in detecting cerebral ischaemia during carotid endarterectomy. Eur J Anaesthesiol (2008) 2.05
Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut (1997) 2.04
Epidemiology of hip fractures in Oslo, Norway. Bone (2001) 2.01
Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum (2011) 2.01
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis (2011) 1.97
Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol (1998) 1.93
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis (2007) 1.87
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis (2008) 1.84
Risk factors for hip fracture in middle-aged Norwegian women and men. Am J Epidemiol (1993) 1.78
Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis (2007) 1.78
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis (2001) 1.78
Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum (2000) 1.77
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Ann Rheum Dis (2006) 1.77
Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (1998) 1.76
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.64
Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (2008) 1.61
Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis (2008) 1.60
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis (2003) 1.58
Does hip strength analysis explain the lower incidence of hip fracture in the People's Republic of China? Bone (2004) 1.57
Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56
Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis (2009) 1.56
Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) (2003) 1.55
EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis (2011) 1.54
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51
A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun (2008) 1.47
Consequences of hip fracture on activities of daily life and residential needs. Osteoporos Int (2004) 1.44
Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease. Scand J Gastroenterol (2002) 1.39
[Use of alendronate in osteoporosis--is it cost-effective?]. Tidsskr Nor Laegeforen (1997) 1.39
[Skiing over Greenland--physical and psychological changes]. Tidsskr Nor Laegeforen (1997) 1.38
Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol (1995) 1.37
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis (2009) 1.36
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol (1999) 1.35
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis (2008) 1.32
Epidemiology of distal forearm fractures in Oslo, Norway. Osteoporos Int (2008) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis (2004) 1.26
Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol (2006) 1.26
Performance of health status measures with a pen based personal digital assistant. Ann Rheum Dis (2005) 1.25
A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. J Rheumatol (2000) 1.24
Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis (2004) 1.24
Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone (2000) 1.23
Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum (1995) 1.21
Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Ann Rheum Dis (2008) 1.20
Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20
Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.18
Hip fracture incidence is decreasing in the high incidence area of Oslo, Norway. Osteoporos Int (2012) 1.18
Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis (2005) 1.18
The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study. Osteoporos Int (2001) 1.17
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17
Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning. Ann Rheum Dis (2005) 1.17
Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis (1982) 1.16
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) (1999) 1.16
Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis (2007) 1.15
Epidemiology of hip fractures in Norway. Acta Orthop Scand (1985) 1.15
The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol (1998) 1.15
Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis (2008) 1.14
Incidence of hip fracture in Oslo, Norway: differences within the city. Bone (1998) 1.14
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) (2008) 1.13
The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology (Oxford) (2000) 1.12
Epidemiology of fractures of the distal forearm in Oslo, Norway. Acta Orthop Scand (1983) 1.11
Ultrasonography shows increased cross-sectional area of the median nerve in patients with arthritis and carpal tunnel syndrome. Rheumatology (Oxford) (2005) 1.10
Musculoskeletal pain and quality of life in patients with noninflammatory joint pain compared to rheumatoid arthritis: a population survey. J Rheumatol (1997) 1.10
Local and national electronic databases in Norway demonstrate a varying degree of validity. J Clin Epidemiol (2005) 1.09
Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.09
Improving risk assessment: hip geometry, bone mineral distribution and bone strength in hip fracture cases and controls. The EPOS study. European Prospective Osteoporosis Study. Osteoporos Int (2002) 1.08
Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis (2008) 1.08